FDA Grants Soligenix "Fast Track" Designation for Dusquetide

PRINCETON, N.J., Jan. 8, 2024 /PRNewswire/ -- Soligenix, Inc. , a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an...

Related Keywords

United Kingdom , Sudan , Japan , Iran , Turkey , China , Canada , British , Robert Hancock , Christopherj Schaber , B Brett Finlay , Biomedical Advanced Research , University Of British Columbia , Twitter , Development Authority , Soligenix Inc , Exchange Commission , Us Congress , Nasdaq , Us Development , National Institute Of Allergy , Prnewswire Soligenix Inc , Defense Threat Reduction Agency , Linkedin , Our Public Health Solutions , Drug Administration , Chief Executive Officer , British Columbia , Middle East , East Asia , Public Health Solutions , National Institute , Infectious Diseases , Project Bioshield , Priority Review Voucher , Markets ,